The Global Cartilage Repair Market Assessed to Propel at $2625.6 Million by 2028

As per Triton's research report, the global cartilage repair market gathered $825.6 million in 2020, and is expected to surge at a CAGR of 15.56% by 2028.

A recent study by Triton Market Research titled 'Global Cartilage Repair Market' includes the Global Analysis and Forecasts by End-user (Hospital & Clinic, Ambulatory Surgical Center, Other End-users), Type (Hyaline Cartilage, Fibrocartilage), Application (Knee, Other Applications), Modality (Autologous Chondrocyte Implantation, Juvenile Allograft Fragment, Microfracture & Chondroplasty, Osteochondral Allograft), Product (Cell-Based, Non-Cell-Based), and by Geography (Middle East and Africa, Asia-Pacific, Latin America, Europe, North America).
Cartilage repair is a type of cartilage restoration procedure wherein the damaged cartilage is switched with the extracellular matrix and new cells.

Request Free Sample of the Global Cartilage Repair Market Report @ https://www.tritonmarketresearch.com/reports/cartilage-repair-market#request-free-sample

Triton's research report suggests that the global market for cartilage repair is likely to experience a growth at a CAGR of 15.56% in revenue through the years 2021-2028. The studied market is further estimated to acquire revenue worth $2625.6 million by 2028.

High incidence of obesity and sports-related injuries are significant elements supporting the growth of the reviewed market. Obesity has adverse effects on the musculoskeletal systems, and is closely related to osteoarthritis. The obesity rates are expected to increase due to multiple factors, such as unhealthy diets, lack of exercise, and others. This growth in incidences of obesity is expected to increase the demand for cartilage repair procedures, thereby supplementing the studied market's progress.

However, the elevated cost of cartilage repair procedures and the shortage of favorable regulations for using cartilage repair products are factors restricting the growth of the cartilage repair market.

The cartilage repair market is segmented into end-user, type, application, modality, and product. In terms of end-user, it is sectioned into hospital & clinic, ambulatory surgical center, and other end-users. Based on type, it is divided into hyaline cartilage and fibrocartilage. The application segment is bifurcated into knee and other applications. Further, the modality section is categorized into autologous chondrocyte implantation, juvenile allograft fragment, microfracture & chondroplasty, and osteochondral allograft. Lastly, product is subdivided into cell-based and non-cell-based.

North America is leading in the cartilage repair market. In the United States, unhealthy lifestyles have resulted in high obesity levels, which are expected to surge in the upcoming years. Here, obesity increases the risk of several health conditions, including joint pain, osteoarthritis, and others. There is a rising demand for cartilage repair products for treating such conditions, which is expected to enhance investments in various institutions in product development. Therefore, the growing obesity levels, along with the growing aging population, are fueling the expansion of the cartilage repair market across North America.

Zimmer Biomet Holdings Inc, Conmed Corporation, B Braun Melsungen AG, Johnson & Johnson, RTI Surgical, Stryker Corporation, Vericel Corporation, Cryolife Inc, Organogenesis Inc, Integra Lifesciences Corporation, Osiris Therapeutics Inc, Smith & Nephew Plc, Arthrex Inc, and Medtronic Plc are widely known companies thriving in the market

Purchase this Report @ https://www.tritonmarketresearch.com/reports/cartilage-repair-market#purchase-option

Question & Answer: Cartilage Repair Market

Question 1: What significant elements are supporting the growth of the cartilage repair market?

Answer: High incidence of obesity and sports-related injuries are significant elements supporting the growth of the reviewed market. Obesity has adverse effects on the musculoskeletal systems, and is closely related to osteoarthritis. The obesity rates are expected to increase due to multiple factors, such as unhealthy diets, lack of exercise, and others. This growth in incidences of obesity is expected to increase the demand for cartilage repair procedures, thereby supplementing the studied market's progress.

Question 2: What factors are restricting the growth of the cartilage repair market?

Answer: The elevated cost of cartilage repair procedures and the shortage of favorable regulations for using cartilage repair products are factors restricting the growth of the cartilage repair market.

Question 3: Which region is leading in the cartilage repair market?

Answer: North America is leading in the cartilage repair market. In the United States, unhealthy lifestyles have resulted in high obesity levels, which are expected to surge in the upcoming years. Here, obesity increases the risk of several health conditions, including joint pain, osteoarthritis, and others. There is a rising demand for cartilage repair products for treating such conditions, which is expected to enhance investments in various institutions in product development. Therefore, the growing obesity levels, along with the growing aging population, are fueling the expansion of the cartilage repair market across North America.

Question 4: Which are the widely known companies thriving in the cartilage repair market?

Answer: Zimmer Biomet Holdings Inc, Conmed Corporation, B Braun Melsungen AG, Johnson & Johnson, RTI Surgical, Stryker Corporation, Vericel Corporation, Cryolife Inc, Organogenesis Inc, Integra Lifesciences Corporation, Osiris Therapeutics Inc, Smith & Nephew Plc, Arthrex Inc, and Medtronic Plc are widely known companies thriving in the market

Related Report:
Global Stem Cell Market
https://www.tritonmarketresearch.com/reports/stem-cell-market

The global stem cell market is estimated to witness growth at a CAGR of 7.54% during the period of 2021-2028, garnering $16782.2 million in revenue by 2028.

Stem cells hold the potential for cutaneous tissue regeneration and supporting wound repair in a paracrine style. The high incidence of chronic diseases globally, owing to the rise in the aging population, has put significant pressure on healthcare infrastructure. This is primarily motivating the growth of the stem cell market.
Factors such as rising awareness about umbilical cord stem cells, growing demand for regenerative medicine, and the surge in stem cell R&D activities support the overall development of the stem cell market.

Furthermore, the technological advancements and risk of adverse immune reactions are opening new avenues for the reviewed market over the forecast period. However, the key market restraints, such as ethical concerns associated with stem cells, the high cost of stem cell procedures, and strict regulations, are hampering the global stem cell market's evolution.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.